PLA1A and hereditary disease: Given that the NMD pathway affects the phenotype of approximately one third of all genetic diseases (Holbrook et al, 2004; Mort et al, 2008), a better understanding of its regulation and factors that influence its function in vivo could be of importance for designing strategies to modulate the NMD response for therapeutic use.